ATW SPAC Management’s Estrella Immunopharma Warrant ESLAW Stock Holding History

ATW SPAC Management’s Portfolio ESLAW Stock Details ESLAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$9.48K	Hold	183,099	–	–	0.01%	127
2025 Q2	$7.59K	Hold	183,099	–	–	0.01%	105
2025 Q1	$16.2K	Hold	183,099	–	–	0.03%	77
2024 Q4	$12.7K	Hold	183,099	–	–	0.02%	89
2024 Q3	$16.2K	Buy	+183,099	New	+$14.8K	0.02%	99
2023 Q4	–	Sell	-183,099	Closed	-$14.3K	–	186
2023 Q3	$44K	Sell	183,099 -11,901	-6%	-$1.97K	0.06%	75
2023 Q2	$10.2K	Hold	195,000	–	–	0.01%	159
2023 Q1	$21.6K	Hold	195,000	–	–	0.01%	120
2022 Q4	$10.1K	Hold	195,000	–	–	﹤0.01%	161
2022 Q3	$13K	Hold	195,000	–	–	﹤0.01%	264
2022 Q2	$49K	Hold	195,000	–	–	0.01%	210
2022 Q1	$44	Hold	195,000	–	–	0.01%	241
2021 Q4	$1.93M	Hold	195,000	–	–	0.3%	110
2021 Q3	$1.93M	Buy	+195,000	New	+$80K	0.36%	80

Other funds holding ESLAW

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

SIA

SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

LCM

Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

ATW SPAC Management's ESLAW Position: Q3 2025 in Review

ATW SPAC Management held its Estrella Immunopharma Warrant (ESLAW) position steady in Q3 2025 at 183,099 shares worth $9.48K. The position accounts for 0.01% of the portfolio, ranked #127.

ATW SPAC Management first reported a position in ESLAW in Q3 2021 and has held it in 14 quarters since. The position peaked at $1.93M in Q4 2021. 12 funds tracked by Wall St. Rank hold ESLAW as of Q3 2025.

ATW SPAC Management held 183,099 shares of Estrella Immunopharma Warrant worth $9.48K as of Q3 2025.
ATW SPAC Management left its Estrella Immunopharma Warrant share count unchanged in Q3 2025.
Estrella Immunopharma Warrant made up 0.01% of ATW SPAC Management's portfolio in Q3 2025, its #127 holding.
ATW SPAC Management first reported a position in Estrella Immunopharma Warrant in Q3 2021 and has held it in 14 quarters since.
ATW SPAC Management's Estrella Immunopharma Warrant position peaked at $1.93M in Q4 2021.
12 funds tracked by Wall St. Rank held Estrella Immunopharma Warrant as of Q3 2025.

Based on ATW SPAC Management's 13F filing for Q3 2025, filed 12 Nov 2025.